Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Anti-Cancer Drugs

• Publication date

  1995-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001813-199508000-00009PMID 7579560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.

  1993cited by this paper
• Optimization of estrogen growth response in MCF-7 cells

  1992cited by this paper
• Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells.

  1992cited by this paper
• Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.

  1991cited by this paper
• Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors

  1991cited by this paper
• Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second‐line therapy in 105 patients

  1991cited by this paper
• Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.

  1991cited by this paper
• The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).

  1990cited by this paper
• Estrogen and progesterone receptors in ovarian cancer

  1990cited by this paper
• Prognostic Significance of Estrogen and Progesterone Receptors in Epithelial Ovarian Cancer

  1990cited by this paper
• What is synergy?

  1989cited by this paper
• Possible role for vitamin D in controlling breast cancer cell proliferation.

  1989cited by this paper
• The interactive effects of alcohol and cocaine on maternal and fetal toxicity in the Long-Evans rat.

  1988cited by this paper
• Adjuvant chemotherapy for breast cancer: 20 years experience using CVFMP chemotherapy.

  1988cited by this paper
• Vitamin D and its revelance to cancer.

  1987cited by this paper
• Retinole acid and glucocorticoids enhance the effect of 1,25‐dihydroxyvitamin D3 on bone γ‐carboxyglutamic acid protein synthesis by rat osteosarcoma cells

  1987cited by this paper
• Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.

  1986cited by this paper
• Review of the application of response surface methodology in the combination therapy of cancer.

  1986cited by this paper
• Synergism and antagonism in the effects of 1 alpha,25-dihydroxyvitamin D3, retinoic acid, dexamethasone, and a tumor-promoting phorbol ester on the functional capability of P388D1 cells: phagocytosis and transglutaminase activity.

  1985cited by this paper
• Cooperative effect of 1 alpha,25-dihydroxyvitamin D3 and dexamethasone in inducing differentiation of mouse myeloid leukemia cells.

  1983cited by this paper
• The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF‐7 cells

  1980cited by this paper

• Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update

  2021cites this paper
• Vitamin D receptor Fok1 polymorphism and invasive ovarian carcinoma risk - A case-control study.

  2020cites this paper
• Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2

  2020cites this paper
• Vitamin D Exposure and Ovarian Cancer Risk and Prognosis

  2020cites this paper
• The preventive effects of indigenous and exogenesis milk and milk products ingredients on cancers

  2018cites this paper
• Vitamin D and Ovarian Cancer

  2017cites this paper
• Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells

  2014cites this paper
• Effects of Milk and Milk Products Consumption on Cancer: A Review

  2013cites this paper
• Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals

  2013cites this paper
• Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

  2012influential citation
• LA VITAMINE D : SES PROPRIETES ET SON UTILISATION EN MEDECINE HUMAINE

  2011cites this paper
• Vitamin D and Vitamin A Receptor Expression and the Proliferative Effects of Ligand Activation of These Receptors on the Development of Pancreatic Progenitor Cells Derived from Human Fetal Pancreas

  2011cites this paper
• Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer

  2010cites this paper
• A systematic literature review of vitamin D and ovarian cancer.

  2010cites this paper
• Circulating 25-Hydroxyvitamin D and Risk of Epithelial Ovarian Cancer

  2010cites this paper
• Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.

  2009cites this paper
• Circulating Vitamin D and Risk of Epithelial Ovarian Cancer

  2009influential citation
• Retinoids in biological control and cancer

  2007cites this paper
• Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer

  2007cites this paper
• Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer.

  2006cites this paper
• Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid

  2006cites this paper
• Dairy food and ovarian cancer risk.

  2006cites this paper
• Expression of VDR and CYP24A1 mRNA in human tumors

  2005cites this paper
• CHAPTER 12 – Vitamin D Receptor Promoter and Regulation of Receptor Expression

  2005cites this paper
• Retinoic acid induced repression of AP‐1 activity is mediated by protein phosphatase 2A in ovarian carcinoma cells

  2005cites this paper
• Molecular Mechanism of Vitamin D Action and its Implications in Ovarian Cancer Prevention and Therapy

  2004cites this paper
• Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs.

  2004cites this paper
• Androgens and ovarian cancers.

  2004cites this paper
• The Emerging Role of Vitamin D in Cancer Risk Reduction

  2003cites this paper
• Normal HC11 and ras-transformed mouse mammary cells are resistant to the antiproliferative effects of retinoic acid.

  2003cites this paper
• Vitamin D analogs in experimental leukemia and transplantation models

  2002cites this paper
• Antiproliferative action of vitamin D.

  2002cites this paper
• Ultraviolet B, vitamin D, and their mechanisms in cancer prevention

  2002cites this paper
• 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.

  2000cites this paper
• Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene.

  2000cites this paper
• Retinoids and ovarian cancer

  2000cites this paper
• 1 , 25-Dihydroxyvitamin D 3 and All-trans-Retinoic Acid Sensitize Breast Cancer Cells to Chemotherapy-induced Cell Death 1

  2000cites this paper
• Expression and clinical significance of apolipoprotein D in epithelial ovarian carcinomas.

  2000cites this paper
• Synergistic inhibition of prostate cancer cell lines by a 19- nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid

  1999cites this paper
• Expression of Retinoic Acid Receptor-β Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog.

  1998cites this paper
• Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog.

  1998cites this paper
• Vitamin-D Analogs : A New Class of Potent Inhibitors of Proliferation and Inducers of Differentiation of Human Myeloid Leukemia Cell Lines

  1998cites this paper
• 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.

  1998cites this paper
• Molecular mechanism of vitamin D receptor action

  1998cites this paper
• Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide.

  1998cites this paper